Drug Development Stocks List

Drug Development Stocks Recent News

Date Stock Title
May 3 LDOS Leidos (LDOS) Recently Broke Out Above the 20-Day Moving Average
May 3 AMPH Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
May 3 LDOS Decoding Leidos Holdings Inc (LDOS): A Strategic SWOT Insight
May 2 RPRX Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
May 2 AMPH Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
May 1 LDOS Leidos Holdings, Inc. (NYSE:LDOS) Q1 2024 Earnings Call Transcript
May 1 ITCI Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
May 1 AMPH Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
May 1 LDOS Leidos Holdings, Inc. (LDOS) Hits Fresh High: Is There Still Room to Run?
May 1 CLNN IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
May 1 LDOS Assessing Leidos Holdings: Insights From 10 Financial Analysts
May 1 LDOS Leidos awarded $206M NGA mission software modernization contract
May 1 LDOS Leidos Holdings Inc (LDOS) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...
Apr 30 LDOS Leidos jumps to record high after earnings beat
Apr 30 ALGS Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
Apr 30 AMPH Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
Apr 30 LDOS Leidos Holdings, Inc. (LDOS) Q1 2024 Earnings Call Transcript
Apr 30 AMPH Why Amphastar (AMPH) Could Beat Earnings Estimates Again
Apr 30 LDOS Why Leidos Stock Is Higher Today
Apr 30 LDOS (LDOS) - Analyzing Leidos Holdings's Short Interest
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags